Freshly Printed - allow 10 days lead
Stroke Prevention in Atrial Fibrillation
Minimize stroke risks in your patients with atrial fibrillation
Greg Flaker (Edited by)
9780323554299, Elsevier Health Sciences
Hardback, published 4 June 2018
202 pages, 100 illustrations (100 in full color)
23.4 x 19 x 1.4 cm, 0.43 kg
Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today’s available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients.
1. Economic and Social Overview of Stroke Related to Atrial Fibrillation 2. Pharmacology of Anticoagulants- VKA and NOAC’s 3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation 4. Risk Stratification 5. Subclinical Atrial Fibrillation 6. The New Anticoagulation Clinic 7. Management of Bleeding Associated with Anticoagulation 8. Periprocedural Management 9. Special Situations: Anticoagulation for Cardioversion 10. Special Situations: Anticoagulation for Ablation 11. Surgical and Implanted Devices for the Left Atrial Appendage 12. Anticoagulation of the Atrial Fibrillation Patient with Other Medical Conditions 13. Stroke and Atrial Fibrillation: The Neurologist's Perspective 14. Atrial Fibrillation and Chronic Kidney Disease
Subject Areas: Cardiovascular medicine [MJD]